Tazobactam sodium salt CAS:89785-84-2

Tazobactam sodium salt, in combination with piperacillin, is used in the treatment of various bacterial infections, including complicated urinary tract infections, intra-abdominal infections, pneumonia, and skin and soft tissue infections. This combination therapy, known as piperacillin-tazobactam, provides broad-spectrum coverage against gram-negative and some gram-positive bacteria. The dosage and duration of piperacillin-tazobactam therapy depend on the specific infection being treated, the patient's renal function, and other individual factors. It is administered intravenously, either intermittently or continuously, under medical supervision. Patients should be aware of potential side effects associated with piperacillin-tazobactam therapy, including gastrointestinal disturbances, allergic reactions, and rare but serious adverse effects like pseudomembranous colitis. Monitoring for adverse reactions during treatment and promptly reporting any unusual symptoms to healthcare providers are important precautions for safe and effective use of tazobactam sodium salt in combination with piperacillin. Consulting with healthcare professionals for personalized treatment recommendations and guidance on managing side effects is essential for optimal patient care.